Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LAMIVUDINE Cause Drug resistance? 1,889 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 1,889 reports of Drug resistance have been filed in association with LAMIVUDINE (Lamivudine and Zidovudine). This represents 11.3% of all adverse event reports for LAMIVUDINE.

1,889
Reports of Drug resistance with LAMIVUDINE
11.3%
of all LAMIVUDINE reports
73
Deaths
220
Hospitalizations

How Dangerous Is Drug resistance From LAMIVUDINE?

Of the 1,889 reports, 73 (3.9%) resulted in death, 220 (11.6%) required hospitalization, and 7 (0.4%) were considered life-threatening.

Is Drug resistance Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LAMIVUDINE. However, 1,889 reports have been filed with the FAERS database.

What Other Side Effects Does LAMIVUDINE Cause?

Foetal exposure during pregnancy (1,905) Virologic failure (1,894) Pathogen resistance (1,733) Viral mutation identified (1,631) Treatment failure (933) Exposure during pregnancy (846) Drug interaction (744) Drug ineffective (726) Immune reconstitution inflammatory syndrome (625) Depression (594)

What Other Drugs Cause Drug resistance?

IMATINIB (1,293) GEFITINIB (1,228) OSIMERTINIB (1,026) NEVIRAPINE (862) PREDNISONE (833) CYCLOPHOSPHAMIDE (817) LEVETIRACETAM (798) METHOTREXATE (765) TENOFOVIR DISOPROXIL (740) RITUXIMAB (732)

Which LAMIVUDINE Alternatives Have Lower Drug resistance Risk?

LAMIVUDINE vs LAMIVUDINE\NEVIRAPINE\ZIDOVUDINE LAMIVUDINE vs LAMIVUDINE\TENOFOVIR LAMIVUDINE vs LAMIVUDINE\TENOFOVIR DISOPROXIL LAMIVUDINE vs LAMIVUDINE\ZIDOVUDINE LAMIVUDINE vs LAMOTRIGINE

Related Pages

LAMIVUDINE Full Profile All Drug resistance Reports All Drugs Causing Drug resistance LAMIVUDINE Demographics